813 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
3 Drug Stocks to Report Earnings on Jul 19: JNJ, NVS, NEOG http://www.zacks.com/stock/news/223699/3-drug-stocks-to-report-earnings-on-jul-19-jnj-nvs-neog?cid=CS-ZC-FT-223699 Jul 18, 2016 - Three drug stocks including industry bellwether Johnson & Johnson (JNJ) will report results on Jul 19.
Facebook (FB) Owns Q2 Earnings on Huge Beat, Plus GRPN, GPRO and More http://www.zacks.com/stock/news/225401/facebook-fb-owns-q2-earnings-on-huge-beat-plus-grpn-gpro-and-more?cid=CS-ZC-FT-225401 Jul 27, 2016 - Facebook (FB) has been priced to near-perfection, and in Q2 2016, it has indeed delivered. And Groupon shoots to the moon after hours.
The 3 Best Dividend Stocks in Arthritis Medication https://www.fool.com/investing/2017/05/22/the-3-best-dividend-stocks-in-arthritis-medication.aspx?source=iedfolrf0000001 May 22, 2017 - Why AbbVie, Pfizer, and Johnson & Johnson rank as the best dividend stocks among arthritis medication companies.
How Regeneron Pharmaceuticals, Inc. Makes Most of Its Money https://www.fool.com/investing/2017/05/31/how-regeneron-pharmaceuticals-inc-makes-most-of-it.aspx?source=iedfolrf0000001 May 31, 2017 - One drug dominates, but diversification is coming.
5 Things Regeneron's CEO Said as the Biotech Stock Sank https://www.fool.com/investing/2017/09/12/5-things-regenerons-ceo-said-as-the-biotech-stock.aspx?source=iedfolrf0000001 Sep 12, 2017 - Regeneron stock dropped on Monday after concerns were raised with clinical results for Dupixent. Here's what the biotech's CEO had to say.
Amgen Inc. (AMGN) CEO Robert Bradway on Q3 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4216261-amgen-inc-amgn-ceo-robert-bradway-q3-2018-results-earnings-call-transcript?source=feed_sector_healthcare Oct 30, 2018 -
Bull of the Day: Regeneron Pharma (REGN) http://www.zacks.com/commentary/53223/bull-of-the-day-regeneron-pharma-regn?cid=CS-ZC--53223 Aug 12, 2015 - Bull of the Day: Regeneron Pharma (REGN)
Biotech Stock Roundup: Acorda Gains on Patent Issues, Vital Crushed by Liver Data http://www.zacks.com/stock/news/187762/biotech-stock-roundup-acorda-gains-on-patent-issues-vital-crushed-by-liver-data?cid=CS-ZC-FT-187762 Aug 26, 2015 - It was a mixed week for the biotech sector with companies like Acorda (ACOR) and BioMarin (BMRN) providing positive updates while others saw their share prices crashing on disappointing data.
The Zacks Analyst Blog Highlights: Amgen, ARIAD, Celgene, Amicus and Alnylam http://www.zacks.com/stock/news/188832/the-zacks-analyst-blog-highlights-amgen-ariad-celgene-amicus-and-alnylam?cid=CS-ZC-FT-188832 Sep 03, 2015 - The Zacks Analyst Blog Highlights: Amgen, ARIAD, Celgene, Amicus and Alnylam
AstraZeneca Strikes Deal with Valeant for Psoriasis Drug http://www.zacks.com/stock/news/188754/astrazeneca-strikes-deal-with-valeant-for-psoriasis-drug?cid=CS-ZC-FT-188754 Sep 02, 2015 - AstraZeneca (AZN) strikes a collaboration agreement with Valeant for the development and commercialization of brodalumab.

Pages: 123456789...82

<<<Page 4>